Competing Drug definition

Competing Drug means, with respect to a Product, a therapeutic product that (i) [***], (ii) [***] and (iii) [***] and (b) “Bioequivalent” or “Bioequivalence” means, a biological product that (i) is highly similar to the Product notwithstanding minor differences in clinically inactive components; and (ii) has no clinically meaningful differences between the biological product and the Product in terms of the safety, purity, and potency.

AI-Powered Contracts

Draft, Review & Redline at the Speed of AI

Competing Drug means a pharmaceutical product that contains a Collaboration Compound as an active ingredient and is bioequivalent to such Product.

Competing Drug shall have the meaning set forth in Section 2.6(b)(i).

Examples of Competing Drug in a sentence

For the avoidance of doubt, this Section 2.6(b)(iii) shall in no way affect the rights and obligations of the parties under Section 2.6(b)(ii), including the respective rights and obligations of the parties upon a withdrawal from the market in the United States of a Competing Drug commercially sold to unaffiliated third parties by ▇▇▇▇ or any of its Affiliates as permitted, or not prohibited, by any settlement of any of the litigation matters set forth as items 2 and 3 on Schedule 5.5.
For the avoidance of doubt, this Section 2.6(b)(iii) shall in no way affect the rights and obligations of the parties under Section 2.6(b)(ii), including the respective rights and obligations of the parties upon a withdrawal from the market in the United States of a Competing Drug commercially sold to unaffiliated third parties by ▇▇▇▇ or any of its Affiliates as permitted, or not prohibited, by any settlement of the litigation matter set forth as item 1 on Schedule 5.5.

More Definitions of Competing Drug

Competing Drug means, with respect to a Licensed Product, a therapeutic product that is not produced, licensed or owned by the GNE Group and that (i) [***], (ii) [***], and (iii) [***]; and (y) “Bioequivalent” or “Bioequivalence” means, a biological product that (i) is highly similar to the Licensed Product notwithstanding minor differences in clinically inactive components; and (ii) has no clinically meaningful differences between the biological product and the Licensed Product in terms of the safety, purity, and potency.

Competing Drug has the meaning set forth in Section 9.5.5 (Competing Drugs).